Avoid Fraud, Get The Facts, And Find The Best
Legal Name: SOFINNOVA INVESTMENTS, INC.
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 13, 2019
Security |
Shares Held / Principal Amount |
Market Value |
Option |
ASCENDIS PHARMA A S (04351P101)
|
1,099,824 |
$126,645k |
|
B. Riley Wealth Management, Inc. (023111206)
|
5,208,305 |
$100,989k |
|
NATERA INC (632307104)
|
3,100,560 |
$85,513k |
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
2,038,208 |
$67,648k |
|
OBSEVA SA (H5861P103)
|
4,749,623 |
$53,718k |
|
SPARK THERAPEUTICS INC (84652J103)
|
481,270 |
$49,272k |
|
Y-MABS THERAPEUTICS INC (984241109)
|
2,104,278 |
$48,125k |
|
COHERUS BIOSCIENCES INC (19249H103)
|
2,093,221 |
$46,260k |
|
NEXTCURE INC (65343E108)
|
2,521,856 |
$37,777k |
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
933,640 |
$35,348k |
|
KARUNA THERAPEUTICS INC (48576A100)
|
1,729,352 |
$34,622k |
|
MERUS N V (N5749R100)
|
1,961,039 |
$28,729k |
|
Nucana Biomed Ltd (GB00BYWYV)
|
2,400,000 |
$24,912k |
|
Nucana Biomed Ltd (67022C106)
|
2,266,666 |
$23,528k |
|
KINISKA PHARMACEUTIC (G5269C101)
|
922,700 |
$12,493k |
|
CHIASMA INC (16706W102)
|
1,630,221 |
$12,178k |
|
ITERUM THERAPEUTICS (G6333L101)
|
1,726,514 |
$11,878k |
|
ENTASIS THERAPEUTICS HOLDING (293614103)
|
1,180,178 |
$7,612k |
|
NOVO-NORDISK AS (670100205)
|
138,371 |
$7,062k |
|
PTC THERAPEUTICS INC (69366J200)
|
156,727 |
$7,053k |
|
ALLERGAN PLC (G0177J108)
|
35,876 |
$6,007k |
|
Neurocrine Biosciences Inc. (64125C109)
|
66,638 |
$5,626k |
|
SYNLOGIC INC (87166L100)
|
574,972 |
$5,232k |
|
HALOZYME THERAPEUTICS INC (40637H109)
|
298,345 |
$5,126k |
|
HERON THERAPEUTICS INC (427746102)
|
262,438 |
$4,879k |
|
TG THERAPEUTICS INC (88322Q108)
|
537,747 |
$4,652k |
|
Reata Pharmaceuticals Inc. (75615P103)
|
49,067 |
$4,629k |
|
Acceleron Pharma Inc (00434H108)
|
102,383 |
$4,206k |
|
ACLARIS THERAPEUTICS INC (00461U105)
|
1,911,573 |
$4,186k |
|
Vertex Pharmaceuticals Inc (92532F100)
|
21,756 |
$3,990k |
|
MACROGENICS INC (556099109)
|
234,661 |
$3,982k |
|
AMGEN INC (031162950)
|
21,400 |
$3,944k |
Put |
MorphoSys AG (D55040105)
|
41,061 |
$3,943k |
|
Allergan plc (G0177J908)
|
21,300 |
$3,566k |
Call |
Bristol-Myers Squibb Co (110122108)
|
74,368 |
$3,373k |
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
36,752 |
$3,148k |
|
DERMIRA INC (24983L104)
|
282,180 |
$2,698k |
|
Incyte Corp (45337C102)
|
29,736 |
$2,526k |
|
AMICUS THERAPEUTICS INC (03152W109)
|
195,220 |
$2,436k |
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
157,799 |
$2,208k |
|
KADMON HOLDINGS INC (48283N106)
|
957,858 |
$1,973k |
|
BRISTOL MYERS SQUIBB CO (110122908)
|
42,700 |
$1,936k |
Call |
ACADIA PHARMACEUTCLS (004225108)
|
66,504 |
$1,778k |
|
ZYMEWORKS INC (98985W102)
|
80,417 |
$1,769k |
|
AKEBIA THERAPEUTICS INC (00972D105)
|
362,177 |
$1,753k |
|
UNIQURE N.V. (N90064101)
|
21,300 |
$1,665k |
Call |
OTONOMY INC (68906L105)
|
585,775 |
$1,611k |
|
ARQULE INC (04269E107)
|
120,403 |
$1,326k |
|
APELLIS PHARMACEUTICALS INC (03753U106)
|
49,580 |
$1,256k |
|
FOAMIX PHARMACUTICLS (M46135105)
|
476,173 |
$1,133k |
|
Xbiotech Inc (98400H102)
|
141,839 |
$1,075k |
|
Zogenix Inc (98978L904)
|
21,200 |
$1,013k |
Call |
Deciphera Pharmaceuticals Inc (24344T951)
|
42,800 |
$965k |
Put |
SYNDAX PHARMACEUTICALS INC (87164F105)
|
103,679 |
$965k |
|
Intra-Cellular Therapies Inc (46116X901)
|
74,300 |
$964k |
Call |
ADVERUM BIOTECHNOLOGIES INC (00773U108)
|
79,453 |
$945k |
|
ABBVIE INC (00287Y109)
|
12,391 |
$901k |
|
CALITHERA BIOSCIENCES INC (13089P101)
|
226,756 |
$884k |
|
OSMOTICA PHARMACEUTICALS PLC (G6S41R101)
|
227,022 |
$863k |
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
11,846 |
$860k |
|
PDS Biotechnology Corporation (70465T107)
|
142,635 |
$854k |
|
Kala Pharmaceuticals, Inc. (483119103)
|
128,557 |
$820k |
|
CLOVIS ONCOLOGY INC COM (189464100)
|
53,576 |
$797k |
|
INTRA-CELLULAR THERAPIES INC (46116X101)
|
53,694 |
$697k |
|
BIOCRYST PHARMACEUTICALS (09058v103)
|
181,159 |
$687k |
|
ACORDA THERAPEUTICS INC COM (00484M106)
|
82,431 |
$632k |
|
FORTY SEVEN INC (34983P104)
|
50,774 |
$538k |
|
APPLIED THERAPEUTICS INC (03828A101)
|
61,330 |
$505k |
|
AUTOLUS THERAPEUTICS PLC (05280R100)
|
28,060 |
$452k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms
Please note: Search data is accumulated by 3rd party and refreshed once per day.